Expression and function of transgenic HLA-DQ molecules and lymphocyte development in mice lacking invariant chain.
Invariant chain (Ii) is a non-MHC-encoded molecule, which plays an accessory role in the proper assembly/expression of functional MHC class II molecules and there by plays an important role in Ag processing/presentation. The phenotype of mice lacking Ii depends on the allotype of the MHC class II molecule. In some mice strains, Ii deficiency results in reduction in expression of class II molecules accompanied by defective CD4(+) T cell development. Responses to conventional Ags/superantigens are also compromised. In this study, we describe for the first time the functionality of human class II molecules, HLA-DQ6 and HLA-DQ8, in transgenic mice lacking Ii. HLA transgenic Ii(-/-) mice expressed very low levels of surface DQ6 and DQ8 accompanied by severe reduction in CD4(+) T cells both in the thymus and periphery. In vitro proliferation and cytokine production to an exogenous superantigen, staphylococcal enterotoxin B (SEB) was diminished in HLA-transgenic Ii(-/-) mice. However, SEB-induced in vivo expansion of CD8(+) T cells expressing TCR Vbeta8 family in DQ8.Ii(-/-) mice was comparable with that of DQ8.Ii(+/+) mice. Systemic IFN-gamma production following in vivo challenge with SEB was reduced in DQ8.Ii(-/-) mice and were also protected from SEB-induced toxic shock. Although the T cell response to a known peptide Ag was diminished in DQ8.Ii(-/-) mice, DQ8.Ii(-/-) APCs were capable of presenting that peptide to primed T cells from wild-type DQ8 mice as well as to a specific T cell hybridoma. Differentiation of mature B cells was also affected to a certain extent in DQ8.Ii(-/-) mice.
Rajagopalan
Govindarajan
G
Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
Smart
Michele K
MK
Krco
Christopher J
CJ
David
Chella S
CS
D000818:Animals; D017951:Antigen Presentation; D000941:Antigens / Q000008:administration & dosage; D000944:Antigens, Differentiation, B-Lymphocyte / Q000235:genetics* / Q000378:metabolism*; D001402:B-Lymphocytes / Q000166:cytology / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology; D002454:Cell Differentiation; D003598:Cytoskeletal Proteins; D004768:Enterotoxins / Q000276:immunology / Q000633:toxicity; D015870:Gene Expression; D006683:HLA-DQ Antigens / Q000235:genetics* / Q000378:metabolism*; D000949:Histocompatibility Antigens Class II / Q000235:genetics* / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000096:biosynthesis; D008213:Lymphocyte Activation; D016131:Lymphocyte Subsets / Q000166:cytology / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D012772:Shock, Septic / Q000209:etiology / Q000235:genetics / Q000276:immunology
D000941:Antigens; D000944:Antigens, Differentiation, B-Lymphocyte; D003598:Cytoskeletal Proteins; D004768:Enterotoxins; D006683:HLA-DQ Antigens; C063831:HLA-DQ6 antigen; C109756:HLA-DQ8 antigen; D000949:Histocompatibility Antigens Class II; C065888:IFI44 protein, human; C045084:invariant chain; C031818:enterotoxin B, staphylococcal; D007371:Interferon-gamma